Prof Saul Faust, co-study leader at the University of Southampton and a consultant paediatrician, said: “These latest results show that this long-acting antibody is safe and could protect thousands of babies from hospitalisation when used in conditions similar to routine clinical practice. It is really important information for the UK to help decide on options for the future national RSV immunisation programme.”
Furthermore, the Saudis will be keenly aware of last year's Israeli strikes on Doha, targeting…
Newly-released security camera footage shows the moment last month's magnitude 6.8 quake shook Kumamoto General…
Israeli prosecutors have charged a settler over the killing of a Palestinian activist in the…
Viruses are not alive and it would take another significant leap for AI to generate…
At least 30 Yemeni government troops are reported to have been killed in Houthi rebel…
Two human rights groups have said an Israeli attack in southern Lebanon that killed al-Akhbar…